Coronavirus Update: April 1, 2020
Medicaid DSH
The following is a revised schedule of Medicaid DSH allotment cuts.
| Before CARES | After CARES | |
| FFY 2020 | $4 Billion | $0 |
| FFY 2021 | $8 Billion | $4 Billion |
| FFY 2022 | $8 Billion | $8 Billion |
| FFY 2023 | $8 Billion | $8 Billion |
| FFY 2024 | $8 Billion | $8 Billion |
| FFY 2025 | $8 Billion | $8 Billion |
| Total | $44 Billion | $36 Billion |
Centers for Disease Control Prevention
The CDC has updated its guidance on responsible actions when among people who have been or may have been exposed to COVID-19.
Food and Drug Administration
The FDA has updated its reporting on the steps it is taking to accelerate the development of novel therapies for COVID-19 through its Coronavirus Treatment Acceleration Program.
The FDA has updated its list of current and resolved drug shortages and continuations. There are currently 148 drugs on the list. Yesterday the FDA posted information regarding shortages of hydroxychloroquine and chloroquine due to a significant surge in demand.
The FDA has issued two additional emergency use authorizations for COVID-19 diagnostics, for a total of 22 authorized tests.
State Department
The State Department has posted a message for foreign medical professionals with approved U.S. non-immigrant or immigrant visa petitions or certificates of eligibility in approved exchange visitor programs or who are already in the U.S. and would like to apply to stay.
The Joint Commission
The Joint Commission has posted a notice expressing support for permitting health care workers to bring their own standard face masks or respirators to use at work when their employers cannot “routinely provide access to protective equipment…”